Speaker(s): 

Natan Babek, MD, Resident Physician, Geisinger - has nothing to disclose.

Moderator:

Varun Pulakanti, MD, Attending Physician, Geisinger- has nothing to disclose.

Learning Objectives:

• to identify the efficacy and safety of extending the treatment window for intravenous alteplase up to 24 hours after stroke onset.
• to recognize the role of perfusion imaging in selecting patients for late-window stroke therapy
• to determine what patients would be candidates for late window thrombolysis would be based on current trial data

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None